Nirmala Devi. P, Bharath Christian C. B. S, Ethel Shiny. S, Vanitha. M


Siddha medicine is an ancient traditional system of medicine healing 4448 diseases in the southern part of India, especially Tamilnadu, Srilanka and Malaysia. Dyslipidemia is a condition which is associated with several morbid manifestations. Generally, dyslipidemia does not have any obvious symptoms but they are usually discovered at routine investigation. But it is a leading cause of death due to atherosclerosis, myocardial infarction and ischemic stroke. Purpose of the study was to treat dyslipidemia with Arjun forte capsule, Siddha oral medicine. Here we present a case that was success with siddha management. Four female patients came to my outpatient department of Santhigiri Siddha Medical College and Hospital, Trivandrum, Kerala, with complaints of difficulty in breathing, no other chronic illness such as Diabetes mellitus/Hypertension. The Lab primary report revealed high levels of serum cholesterol LDL, and Triglycerides. No treatment has been taken so far regarding this issue. I was given 2month treatment of capsule Arjun Forte as an internal medicine along with diet and lifestyle modifications. Excellent results observed ultimately. The amount of lipids in blood came to normal in a lab report and symptoms of difficulty in breathing at night were completely relieved. So, It could be concluded as efficacy of Arjun Forte excellent in treating dyslipidemia.

Keywords: Siddha management, Dyslipidemia, Capsule-arjun forte, Specific diet, Metabolic dysfunction, Lifestyle disorders, Herbo mineral drug.

Full Text:



Thas JJ. Siddha. medicine-background and principles and the application for skin diseases. Clin Dermatol 2008;26(1):62-78. doi: 10.1016/j.clindermatol.2007.11.010.

Hill MF, Bordoni B. dyslipidemia. [Updated 2023 Aug 8]. In: Stat Pearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559182/

American Diabetes Association. Standards of medical care in diabetes--2012. Diabetes Care. 2012;35 Suppl 1(Suppl 1):S11-63. doi: 10.2337/dc12-s011.

Yang YS, Kim HL, Kim SH, Moon MK. Lipid management in Korean people with type 2 diabetes mellitus: Korean Diabetes ASSOCIATION and Korean Society of lipid and Atherosclerosis consensus statement. Diabetes Metab J 2023;47(1):1-9. doi: 10.4093/dmj.2022.0448. Epub 2023 Jan 20.

El-Sayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, On behalf of the American Diabetes Association. Summary of Revisions: Standards of Care in Diabetes-2023. Diabetes Care. 2023;46(Suppl (1):S5-S9. doi: 10.2337/dc23-Srev.

Sizar O, Khare S, Patel P, et al. Statin Medications. [Updated 2024 Feb 29]. In: Stat Pearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430940/

Padda IS, Mahtani AU, Parmar M. Sodium-Glucose Transport Protein 2 (SGLT2) Inhibitors. [Updated 2023 Jun 3]. In: StatPearls [Internet]. Treasure Island (FL): Stat Pearls Publishing; 2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK576405/

Siddha Treatment Guidelines for Selected Diseases. (2014). National Institute of Siddha

Santhigiri Health Care and Research Organisation Products Therapeutic index.

Nie Y, Luo F. Dietary Fiber: An Opportunity for a Global Control of dyslipidemia. Oxid Med Cell Longev. 2021:5542342. doi: 10.1155/2021/5542342

Murugesa Mudhaliar. Gunapadam Mooligai Vaguppu . Dept of Indian Medicine and Homeopathy. Chennai. Govt of Tamilnadu. Edition.2006;1:70-480

Thiagarajan R, Siddha material medica (Mineral & Animal Kingdom) Published by Directorate of Indian medicine and Homeopathy. Chennai. 106. 2008.


  • There are currently no refbacks.